Back

A long-acting prolactin to combat lactation insufficiency

Kready, K.; Doiron, K.; Redfield Chan, K.; Way, J. C.; Justman, Q.; Powe, C. E.; Silver, P. A.

2023-12-15 synthetic biology
10.1101/2023.12.15.571886 bioRxiv
Show abstract

Human infants are born to breastfeed. While 50% of lactating persons struggle to make enough milk, there are no governmentally-approved drugs to enhance lactation1. Here, we engineer a variant of the naturally-occurring driver of lactation, the hormone Prolactin, to increase its serum half-life and produce a viable drug candidate. Our engineered variant, Prolactin-eXtra Long-acting (Prolactin-XL), is comprised of endogenously active human prolactin fused to an engineered human IgG Fc domain designed to overcome the unique drug development challenges specific to the lactating person-infant dyad. Our Prolactin-XL has a serum half-life of 70.9h in mice, 2,625-fold longer than endogenously active prolactin alone (70.9h v. 0.027h). We demonstrate that Prolactin-XL increases milk production and restores growth of pups fed by dams with pharmacologically-ablated lactation. We show that Prolactin-XL-enhanced lactation is accompanied by reversible, lactocyte-driven changes in mammary gland morphology. This work establishes long-acting prolactins as a potentially powerful pharmacologic means to combat insufficient lactation.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 3%
29.9%
Similar papers in this journal
2
Nature
○ 645 papers in training set
Top 2%
10.2%
Similar papers in this journal
3
Science
● 477 papers in training set
Top 0.9%
7.6%
Similar papers in this journal
4
Nature Chemical Biology
○ 119 papers in training set
Top 0.2%
7.0%
Similar papers in this journal
50% of probability mass above
5
Science Advances
● 1243 papers in training set
Top 3%
6.5%
Similar papers in this journal
6
Cell
○ 431 papers in training set
Top 2%
4.7%
7
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 12%
4.2%
8
Nature Metabolism
○ 69 papers in training set
Top 0.8%
2.4%
9
eLife
● 5828 papers in training set
Top 47%
2.0%
10
Neuron
○ 337 papers in training set
Top 3%
2.0%
11
Science Translational Medicine
● 127 papers in training set
Top 1%
1.8%
12
Nature Structural & Molecular Biology
236 papers in training set
Top 2%
1.8%
13
Nature Biotechnology
○ 172 papers in training set
Top 3%
1.7%
14
Nature Neuroscience
○ 252 papers in training set
Top 4%
1.4%
15
Cancer Cell
○ 42 papers in training set
Top 1%
1.1%
16
Nature Biomedical Engineering
○ 47 papers in training set
Top 1%
1.0%
17
Cell Chemical Biology
○ 94 papers in training set
Top 1%
1.0%
18
Nature Genetics
○ 286 papers in training set
Top 5%
1.0%
19
Cell Reports Medicine
○ 153 papers in training set
Top 5%
0.8%
20
Communications Biology
○ 993 papers in training set
Top 32%
0.8%
21
Advanced Science
○ 286 papers in training set
Top 10%
0.8%
22
ACS Synthetic Biology
● 287 papers in training set
Top 2%
0.8%
23
Cell Reports
○ 1498 papers in training set
Top 28%
0.8%
24
ACS Central Science
● 71 papers in training set
Top 2%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.